The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 185.00
Bid: 178.50
Ask: 188.00
Change: 0.00 (0.00%)
Spread: 9.50 (5.322%)
Open: 185.00
High: 188.50
Low: 185.00
Prev. Close: 185.00
NXR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

1 Apr 2020 07:00

RNS Number : 3109I
Norcros PLC
01 April 2020
 

1 April 2020

 

("Norcros", the "Group" or the "Company")

 

Trading update and impact of the Coronavirus

 

 

In light of the rapidly changing developments regarding COVID-19 (Coronavirus) since our last announcement on 20 February 2020, Norcros, a market leading supplier of high quality and innovative bathroom and kitchen products is today providing a further update on the potential impact on its performance for the year to 31 March 20201 and the measures it is taking to manage the associated risks.

 

The safety and wellbeing of our staff has been paramount in our considerations along with our key principle of doing the right thing at the right time for all our key stakeholders.

 

Trading update

 

The Group has continued to win market share in its major markets despite conditions remaining challenging and up until recently remained in line to meet market expectations for this financial year. Recent Government measures in both the UK and South Africa to contain the spread of the COVID-19 pandemic means that this is now no longer the case as demand in our seasonally important Period 12 has slowed markedly as our customers have focussed on how they mitigate the risks of COVID-19.

 

 

Impact of the COVID -19 pandemic

 

On 20 February 2020, we reported that the slower than anticipated return to full production at our China based suppliers would impact this year's financial performance. Whilst our China supply chain is now operating at close to normal levels the nature and the extent of the commercial impact has changed significantly moving from a supply chain issue into a global demand one.

 

The South African Government issued a directive on 23 March 2020 requiring a 21-day national lockdown, effective midnight 26 March 2020 to midnight 16 April 2020 in order to contain the spread of the COVID -19 pandemic. Consequently, we have mothballed all of our operations and trading has ceased. The situation however remains fluid and is being closely monitored and actively managed.

 

In the UK, we have been in active discussions with our customers to better understand how they are planning to trade during the coming weeks following the recently introduced Government measures.

It is now evident that the majority have temporarily closed their main outlets except for products which are deemed essential and sold through their click and collect operations. Trading is therefore minimal. Consequently, we have suspended our main manufacturing and assembly operations in the UK in a controlled way to safeguard our workforce and to ensure an efficient resumption at the appropriate time.

 

We now expect our underlying operating profit2 for the year to 31 March 20201 to be approximately £31m compared to the previous consensus forecast of £35m. All of this reduction is attributable to the COVID-19 situation, is considered both temporary and exceptional, and follows a period of robust trading including market share gains.

 

Given these circumstances and the high degree of uncertainty, we are suspending our previous guidance for the financial year 2020/21.

 

 

Short term COVID -19 response measures

 

Immediate action has been taken to preserve the cashflow of the business. Actions include deferring all non-essential capital expenditure and all discretionary operating expenditure.

 

We have very well-established relationships with our customers and suppliers, and we will continue to prudently manage our working capital given the current level of uncertainty.

 

We welcome the recent measures announced by the UK Government to support businesses through this challenging period and the Group will look to use this support where applicable. Our cash flows will benefit from a number of them, furthermore we will access the Government's Job Retention Scheme to help us secure jobs during the suspension or curtailment of our operations.

 

 

Financial position and liquidity

 

The Group is in a strong financial position and has a low level of net debt2. Year-end net debt2 is expected to be c.£40m and leverage (net debt2 to EBITDA) circa 1.1x. Our bank covenant ratio is for net debt2 to EBITDA to be less than 3.0x.

 

The Group has access to a £120million committed RCF financing facility, plus a £30million accordion facility, which mature in November 2022 and has drawn down £84m on the RCF facility to ensure that it has sufficient short-term liquidity.

 

We have modelled a number of different potential scenarios of different durations and severity including periods of nil revenues followed by periods of reduced revenues and assessed the impact on both profitability and cash flow over the next 12 months. We are confident that with the actions being taken to preserve cash and the financial resources available to it, mean that the Group is well placed to withstand an extended period of reduced trading.

 

 

Dividend

 

The Board will consider the appropriateness, quantum and timing of any final dividend payment for this financial year when it has a clearer view of the scale and duration of the COVID-19 impact on the business.

 

 

Comment from Nick Kelsall, Group Chief Executive

 

"These are unprecedented times, with our most important consideration being the health and safety of our employees, customers, and all other stakeholders. Norcros has a strong balance sheet and the Board is confident that the short term actions being taken in response to the impact of the global COVID-19 pandemic together with the Group's leading market positions, strong brands and broad distribution channels will enable it to return to growth as soon as practicable.

 

The current uncertainty means that we have to focus on short term measures which need to be balanced with the objective of ensuring our business emerges well-positioned to progress our longer term strategy."

 

 

1.The accounting reference ' year to 31 March 2020 ' relates to the 53-week accounting period commencing on 1 April 2019 and ending 5 April 2020

2.Pre IFRS16

 

 

 

Enquiries: 

 

 Norcros plc

Tel: 01625 547 700

 Nick Kelsall, Group Chief Executive

 

 Shaun Smith, Group Finance Director

 

 

 

 

 

 Hudson Sandler

Tel: 0207 796 4133

 Nick Lyon

 Toby Andrews

 

 

 

 

 

Notes to Editors

 

· Norcros is a market leading supplier of high quality and innovative bathroom and kitchen products with operations primarily in the UK and South Africa.

 

· Based in the UK, Norcros operates under seven brands:

· Triton - Market leader in the manufacture and marketing of showers in the UK

· Merlyn - The UK and Ireland's No. 1 supplier of shower enclosures and trays to the residential, commercial and hospitality sectors

· Vado - A leading manufacturer and supplier of taps, mixer showers, bathroom accessories and valves

· Croydex - A market-leading, innovative designer, manufacturer and distributor of high quality bathroom furnishings and accessories

· Abode - A leading niche designer and distributor of high quality kitchen taps, bathroom taps and kitchen sinks

· Johnson Tiles - The leading manufacturer and supplier of ceramic tiles in the UK

· Norcros Adhesives - Manufacturer of tile & stone adhesives, grouts and related products

 

· Based in South Africa, Norcros operates under four brands:

· Tile Africa - Chain of retail stores focused on ceramic and porcelain tiles, and associated products such as sanitary ware, showers and adhesives

· Johnson Tiles South Africa - Manufacturer of ceramic and porcelain tiles

· TAL - The leading manufacturer of ceramic and building adhesives

· House of Plumbing - Market leading supplier of specialist plumbing materials

 

· Norcros is headquartered in Wilmslow, Cheshire and employs around 2,200 people. The Company is listed on the London Stock Exchange. For further information please visit the Company website: http://www.norcros.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBLGDXSUXDGGB
Date   Source Headline
25th Apr 20247:00 amRNSSale of Johnson Tiles UK
22nd Apr 20242:00 pmRNSInvestor Webinar 7 May 2024
12th Apr 20243:40 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSTrading update
28th Mar 20247:00 amRNSBlock listing Six Monthly Return
28th Mar 20247:00 amRNSVoting Rights and Share Capital Update
1st Mar 20242:09 pmRNSDirectors Share Dealing
23rd Jan 202411:40 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSAppointment of Joint Corporate Broker
22nd Dec 20237:00 amRNSEmployee SAYE awards and director share dealing
1st Dec 20234:35 pmRNSDirector Declaration
23rd Nov 20234:06 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
3rd Nov 20239:00 amRNSInvestor Presentation
12th Oct 20237:00 amRNSTrading Update
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
11th Aug 20234:36 pmRNSDirector's Dealings
26th Jul 20234:50 pmRNSResults of AGM
26th Jul 20231:06 pmRNSDirector's Dealings
26th Jul 20237:00 amRNSAGM Trading Statement
10th Jul 20235:59 pmRNSDirector's Dealings
23rd Jun 20237:00 amRNSAnnual Financial Report and Notice of 2023 AGM
15th Jun 20237:00 amRNSFinal Results
30th May 20237:00 amRNSDirectorate Changes
13th Apr 20237:00 amRNSTrading Update
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20234:16 pmRNSHolding(s) in Company
21st Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20233:19 pmRNSBlock Listing Six Monthly Return
14th Feb 20237:00 amRNSDirectorate Update
30th Jan 20237:00 amRNSCEO Succession
24th Jan 20237:00 amRNSDirectorate Update
15th Dec 20229:40 amRNSBoard Changes
9th Nov 20227:00 amRNSInterim Results
1st Nov 202212:07 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
30th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 20227:00 amRNSVoting Rights and Share Capital Update
13th Sep 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20229:39 amRNSVoting Rights and Share Capital Update
26th Jul 202212:30 pmRNSHolding(s) in Company
25th Jul 20222:23 pmRNSDirectors' Dealings
19th Jul 20222:05 pmRNSResults of AGM
19th Jul 20221:57 pmRNSDirector Dealings
19th Jul 20227:00 amRNSAGM Trading Statement
15th Jul 20225:08 pmRNSVoting Rights and Share Capital Update
30th Jun 20229:08 amRNSVoting Rights and Share Capital Update
21st Jun 20225:21 pmRNSDirector Declaration
16th Jun 202211:16 amRNSNotice of AGM Annual Report Announcement
14th Jun 20222:25 pmRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.